Table 1 Summary of Patients with GBM who Received AKC immunotherapy
Patient | Prior recurrence | Survival at last F/U | OS (month) | PFS (month) | KPS | IDH1 status |
|---|---|---|---|---|---|---|
A1 | 2 | Alive | 76 | 76 | 70 | wild-type |
A2 | 2 | Dead | 11 | 5 | 60 | wild-type |
A3 | 1 | Dead | 10 | 7 | 60 | wild-type |
A4 | 2 | Dead | 27 | 12 | 80 | wild-type |
A5 | 2 | Dead | 18 | 5 | 70 | wild-type |
A6 | 2 | Alive | 51 | 21 | 70 | wild-type |
A7 | 1 | Alive | 52 | 52 | 80 | wild-type |
A8 | 1 | Dead | 3 | 2 | 60 | wild-type |
A9 | 1 | Dead | 12 | 7 | 70 | mutation |
A10 | 2 | Dead | 18 | 9 | 60 | wild-type |
A11 | 2 | Alive | 36 | 36 | 80 | wild-type |
A12 | 1 | Dead | 8 | 5 | 60 | wild-type |
A13 | 1 | Dead | 28 | 22 | 70 | wild-type |
A14 | 1 | Alive | 28 | 28 | 90 | wild-type |